Low & Intermediate Risk Neuroblastoma
Dr. Holly Meany focuses on the treatment of low and intermediate-risk neuroblastoma (non-high-risk neuroblastoma). Dr. Meany shares how overall the story of non-high-risk neuroblastoma is a successful one, and describes how the success came about, what challenges have been identified and the questions that remain to be answered. This is a recorded presentation from the 2020 symposium.
▶︎
What is neuroblastoma and post-maintenance therapies
▶︎
Neuroblastoma Basics: Introduction to Neuroblastoma
▶︎
The Devastating Effects Of Stage 4 Cancer
▶︎
Doctors Said It Was ANXIETY But It Was CANCER! - Melissa | Stomach Cancer | The Patient Story
▶︎
BEACON2: Expanding Treatment Options for Relapsed Neuroblastoma
▶︎
The Most Accurate Medical Drama Of All Time? | The Pitt
▶︎
Understanding Current Frontline Treatment: COG and SIOPEN
▶︎
Why Can’t We Cure Cancer? A National Conversation | Full CUOMO Special Edition 2/27
▶︎
Medical Historian Answers History of Medicine Questions | Tech Support | WIRED
▶︎
I Witnessed a Hard Death. Here’s What Families Need to Know.
▶︎
But what is quantum computing? (Grover's Algorithm)
▶︎
Wenn der Tod ein Anfang ist | Die Nordreportage | NDR
▶︎
AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎
Treating relapsed and refractory disease
▶︎
The MINT Study: Addressing Unmet Need in High‑Risk Neuroblastoma
▶︎
Measuring response to treatment
▶︎
Nicole lives ina DIY wooden tiny house surrounded by nature | ARD Room Tour
▶︎
Hope in survivorship
▶︎
Overcoming Grade 4 Glioblastoma: Ed’s Story
▶︎